| Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations SO Ciurea, A Chilkulwar, RM Saliba, J Chen, G Rondon, KP Patel, ... Blood, The Journal of the American Society of Hematology 131 (26), 2989-2992, 2018 | 72 | 2018 |
| Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and … P Kongtim, S Parmar, DR Milton, JMR Perez, G Rondon, J Chen, ... Bone marrow transplantation 54 (6), 839-848, 2019 | 29 | 2019 |
| Maintenance therapy in multiple myeloma P Mewawalla, A Chilkulwar Therapeutic advances in hematology 8 (2), 71-79, 2017 | 19 | 2017 |
| Industry payment to vascular neurologists: a 6-year analysis of the open payments program from 2013 through 2018 K Nalleballe, S Sheng, C Li, R Mahashabde, AR Annapureddy, ... Stroke 51 (4), 1339-1343, 2020 | 16 | 2020 |
| Case series of unique adverse events related to the use of ibrutinib in patients with B-cell malignancies—a single institution experience and a review of literature H Shaikh, A Khattab, MS Faisal, A Chilkulwar, M Albrethsen, S Sadashiv, ... Journal of Oncology Pharmacy Practice 25 (5), 1265-1270, 2019 | 10 | 2019 |
| Serum Free Light Chain Concentration (> 1000mg/Dl) at Diagnosis and at Relapse Predicts for Very Poor Prognosis in Multiple Myeloma A Chilkulwar, P Mewawalla, A Miller, G Berteotti, E Sahovic, J Lister Blood 128 (22), 5698, 2016 | 5 | 2016 |
| Leptomeningeal carcinomatosis associated with papillary renal cell carcinoma A Chilkulwar, R Pottimutyapu, F Wu, KR Padooru, SR Pingali, M Kassem ecancermedicalscience 8, 2014 | 5 | 2014 |
| Hemophagocytic lymphohistiocytosis secondary to bone marrow only B-cell lymphoma: A very rare entity with an even rarer presentation A Patel, A Vakiti, A Chilkulwar, P Mewawalla Journal of Hematology 6 (2-3), 49, 2017 | 4 | 2017 |
| Herpes zoster in chronic lymphocytic leukemia: Effect of vaccination and treatment. N Antao, AR Chilkulwar, S Luo, KR Carson, KM Sanfilippo, MW Schoen Journal of Clinical Oncology 39 (15_suppl), 7527-7527, 2021 | 3 | 2021 |
| Safe prolonged use of brentuximab vedotin in a patient with Classical Hodgkin Lymphoma on hemodialysis A Schad, AR Pakanati, S Woelich, A Chilkulwar Current Problems in Cancer: Case Reports 11, 100249, 2023 | 2 | 2023 |
| Bleomycin-induced pulmonary toxicity: A retrospective review of incidence and risk factors. P Tayshetye, P Padhi, R Rao, TY Sklyar, A Chilkulwar, R Miller, A Tang, ... Journal of Clinical Oncology 36 (15_suppl), e16532-e16532, 2018 | 2 | 2018 |
| Dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, doxorubucin and rituximab (da-EPOCH-R) vs rituxan, cyclophosphamide, doxorubucin, vincristine and prednisone … P Padhi, A Chilkulwar, C Khan, M Patel, J Lister, X Tang Blood 128 (22), 5410, 2016 | 1 | 2016 |
| High serum free light chain concentration (> 1000mg/dl) at the time of relapse to predict poor prognosis in multiple myeloma. A Chilkulwar, A Miller, P Mewawalla, G Berteotti, A Kaminsky, ... Journal of Clinical Oncology 34 (15_suppl), 8064-8064, 2016 | 1 | 2016 |
| Induction Therapy with Dasatinib and Prednisone for Patients with Philadelphia Positive ALL A Chilkulwar, S Fazal, JT De Yao, P Padhi, C Khan, J Lister Blood 126 (23), 4907, 2015 | 1 | 2015 |
| The Effect of Chromosome 1q21 Abnormalities on Outcomes of Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma Patients JS Moreb, L Lantos, A Edwards, F Chen, J Dugan, AP Skarbnik, K Elliott, ... Transplantation and Cellular Therapy, Official Publication of the American …, 2024 | | 2024 |
| COVID 19 Infection in Autologous Stem Cell Transplant (ASCT) Recipients-A Single Institution Observational Cohort JS Moreb, A Edwards, S Perry, J Dugan, R Thertulien, K Elliott, ... Medical Research Archives 11 (7.2), 2023 | | 2023 |
| Delay in COVID-19 Presentation in Patients Recently Treated with CD-19 Directed CAR-T Therapy N Wuliji, SD Goyal, M Fesler, AR Chilkulwar, A Babic Transplantation and Cellular Therapy 28 (3), S203, 2022 | | 2022 |
| Delay in COVID-19 Presentation in Patients Recently Treated with CD-19 Directed CAR-T Therapy MO Natalie Wuliji, DO, Saint Louis University, Saint Louis, ... TCT, 2021 | | 2021 |
| Donor Sex, Age, and Body Mass Index on Bone Marrow Harvest Collection Quality Outcomes M Mehta, AR Chilkulwar, K McCormick, J Kelly, SM Pincus, JM Richart Biology of Blood and Marrow Transplantation 26 (3), S278, 2020 | | 2020 |
| Multiple Myeloma: Trends in Consulting Fees and Drug Utilization D Chakos, A Farooqui, K McCormick, AR Chilkulwar Blood 134, 5823, 2019 | | 2019 |
